⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
InnoCare Announces Strategic Research Collaboration and License Agreement with Lilly to Develop New Medicines
globenewswire.com
LLY
HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2026
globenewswire.com
HCM
LLY
AZN
Global Protein Expression Market to Reach USD 7.30 Billion by 2034 at 8.8% CAGR as Rising Biopharmaceutical Development, Growing Demand for Recombinant Proteins, and Advances in Cell-Free Expression Technologies Accelerate Market Growth, Reports Maximize
prnewswire.com
TMO
AMGN
AGNC
BIO
QGEN
BIIB
GILD
REGN
BMY
MRK
SNY
LLY
ABBV
PFE
JNJ
AZN
BSX
MDLZ
GEHC
SYK
EW
ISRG
GOOG
MSFT
NVDA
AMAT
KLAC
LRCX
INTC
AMD
MU
WDC
SE
CRM
IBM
ORCL
SAP
ACN
GEN
PRG
EXAS
DXCM
ALGN
IDXX
VRTX
XRAY
CTAS
MDT
AMZN
GOOGL
CTSH
INFY
HPE
DELL
HPQ
LOGI
ADBE
CDNS
SNPS
MRVL
QCOM
NXPI
ON
ADI
TXN
MCHP
QRVO
NTAP
STX
WD
CRWD
PANW
FTNT
DDOG
SNOW
ETSY
ROKU
PYPL
MELI
JD
BABA
NTES
PDD
IQ
VIPS
NIO
LI
XPEV
RIVN
TSLA
GM
F
STLA
TM
VWAGY
HOG
Sleep Apnea Clinical Trial Pipeline Shows Potential with Active Contributions from 22+ Key Companies | DelveInsight
globenewswire.com
LLY
APMD
RMD
PHG
CMPS
T. ROWE PRICE EXPLORES WHAT INVESTORS CAN LEARN FROM SHELL CEO'S VIEW OF AN "ENERGY ADDITION" ERA
prnewswire.com
TROW
NVDA
XOM
LLY
F
HON
GE
NYT
ISRG
CSCO
ORCL
TMUS
GS
INTC
HLT
Forge’s Fierce Pharma Week Delivered a Powerhouse Event with Over 3,500 Pharmaceutical and Biotech Decision-Makers and Innovators, Representing a 21% Increase in Attendees Over 2025
globenewswire.com
ABBV
ACAD
AZN
BIIB
BMY
LLY
GILD
PFE
REGN
TEVA
Obesity Treatment Landscape 2026: Obesity Competitive Landscape and Clinical Trial Analysis 2026 Examines 200+ Companies and 200+ Drugs
globenewswire.com
LLY
NVO
NBIX
WVE
ALV
PFE
ABBV
AMGN
VKTX
ALNY
Alzheimer's Disease Competitive Landscape and Clinical Trial Analysis Report 2026: More Than 200 Companies and 240 Therapies Assessed
globenewswire.com
LLY
BIIB
JNJ
SNY
ALNY
ABBV
BMY
REGN
XCUR
Global Lupus Nephritis Market to Reach USD 4.08 Billion by 2034 at 8.5% CAGR as Rising Disease Burden and Breakthroughs in Targeted Therapies Accelerate Market Expansion, Says Maximize Market Research
prnewswire.com
PFE
AZN
MRK
BMY
GSK
AMGN
BIIB
JNJ
VRTX
IMVT
ABBV
LLY
SNY
REGN
GILD
BHC
AUR
UCB
Global Alzheimer’s Disease Biomarker Market Poised for Phenomenal Expansion at a Growth Rate of ~9% by 2034 | DelveInsight
globenewswire.com
ABT
BIO
AMGN
BMY
AXSM
JNJ
LLY
NVO
QTRX
DGX
TMO
QRVO
GILD
REGN
BIIB
ALKS
ACAD
PTGX
CRIS
EXAS
TDOC
QRHC
AMZN
GOOG
MSFT
IBM
NVDA
INTC
AMD
QCOM
AMAT
LRCX
KLAC
MU
ADI
NXPI
TXN
MRVL
ON
CDNS
SNPS
MCHP
AEHR
ENPH
PLUG
FCEL
PLTR
AI
CRBU
EDIT
BEAM
NTLA
BNTX
MRNA
PFE
JAZZ
ACGL
ZBRA
MSCI
ROST
SWKS
MDT
TNDM
XRAY
ALGN
IDXX
EXPE
CTAS
ILMN
DXCM
ASML
ADBE